secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImageneBio, Inc. (IMA)
CIK:        0001835579
Form:       8-K
Filed at:   2025-07-24T23:59:59+00:00
Accession:  0001193125-25-163990
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Ikena Oncology to effect 1-for-12 reverse stock split, rename to ImageneBio, ticker IMA
--------------------------------------------------------------------------------

- 1-for-12 reverse stock split effective July 28, 2025; shares outstanding drop from ~48.2M to ~4M.
- Company will rename ImageneBio, Inc., trade under ticker "IMA" on Nasdaq, new CUSIP 45175G207.
- No fractional shares; cash paid based on July 24 closing price multiplied by fractional share.
- Exercise prices and shares underlying equity awards will be proportionally adjusted; par value unchanged.
- Stockholders in book-entry or brokerage accounts need no action; beneficial holders contact broker.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835579/000119312525163990/0001193125-25-163990-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835579/000119312525163990/d21564d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-163990

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer